A new drug application for apixaban for stroke prophylaxis in patients with nonvalvular AF was submitted to the Food and Drug Administration (FDA) in 2011. [22] ...

Three new oral anticoagulants (dabigatran, rivaroxaban and apixaban) have been recently approved across the world for stroke prevention in AF. Despite their efficacy; their usage in CKD patients ...

Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...

Atrial fibrillation emerged as a frequent and potentially prognostic complication in wild-type transthyretin amyloidosis, ...

Non-valvular atrial fibrillation accounts for 13–26% of acute ischaemic strokes.1 Direct oral anticoagulants (DOACs) are ...

Background and objective Prior studies have suggested that patients with premature ventricular complexes (PVCs) may have an ...

In-hospital, all-cause mortality among critically ill patients with AF is associated with the Endothelial Activation and Stress Index.

According to the manufacturer of Eliquis, in 2025, the list price for a 30-day supply of Eliquis is $606, but Medicare beneficiaries pay, on average, $54 per month. And 5 out of 10 people on ...

Targeted ablation guided by voltage mapping improved rhythm outcomes in individuals with recurrent atrial fibrillation after ...

Outcomes in the observational study were better among patients treated by surgeons who regularly do ablations.